New partnership will ‘reduce risk and improve patient safety’

Forescout Technologies, a specialist in device visibility and control, has announced a strategic partnership with dedicated medical device security and asset management solutions company, Medigate.

This partnership will aim to help healthcare organisations continuously discover, identify, assess and secure all Internet of Medical Things (IoMT), IoT, Operational Technology (OT) and IT network connected devices. Forescout also plans to resell the Medigate Platform.

“Connected medical devices represent a fast-growing threat attack vector and the lack of device manufacturer standardisation and interoperability has created a significant problem for clinical care network operations,” said Pedro Abreu, chief product and strategy officer, Forescout. “The combination of Medigate’s deep knowledge of medical devices and the healthcare industry with Forescout’s breadth of device intelligence adds a new level of cohesive device insight, expertise and security for the healthcare industry.”

The partnership will enable passive technologies to identify and classify all connected medical devices and IT assets on health delivery organisation networks, including unknown and hard-to-classify devices, while minimising disruption. It will also provide valuable insights to support corporate security policies to protect biomedical devices through effective vulnerability management, anomaly and threat detection and risk scoring. Through this collaboration, customers will be able to design and implement effective segmentation and control access to the clinical network.   

“The Medigate and Forescout partnership and integration provide healthcare organisations with rich contextual visibility into their IT and clinical networks, as well as sophisticated network analysis to detect threats and implement clinically-driven policies,” said Jonathan Langer, co-founder and CEO, Medigate. “These actionable insights will, in turn, reduce risk and improve patient safety.”

This partnership hopes to reduce complexity of the following factors for customers in enterprise and specialised medical environments: Device visibility, classification, compliance and cybersecurity protection.